ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+49.8%
5Y CAGR+43.4%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+49.8%/yr
vs +30.4%/yr prior
5Y CAGR
+43.4%/yr
Recent acceleration
Acceleration
+19.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
6.1x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$34.09M+25.0%
2024$27.28M+22.1%
2023$22.34M+120.1%
2022$10.15M+247.7%
2021$2.92M-48.0%
2020$5.61M-53.8%
2019$12.16M+246.7%
2018$3.51M-15.0%
2017$4.13M+49.3%
2016$2.76M-